Work

Bortezomib (PS-341) in Relapsed or Refractory Extensive Stage Small Cell Lung Cancer: A Southwest Oncology Group Phase II Trial (S0327)

Year: 2006
Type: article
Study design: Clinical Trial
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: bronze
Awards: G1033243903, Greenville SC CCOP, G1202672505, SOUTHWEST ONCOLOGY GROUP, G1375689152, Columbus Community Clinical Oncology Program (Columbus CCOP), U10 Full Member Application Affiliated with SWOG, G1646027999, G1790576020, G1958973285, G2064543036, Scott & White Community Clinical Oncology Program, G2397742718, G268786457, WESTERN ONCOLOGY RESEARCH CONSORTIUM, Southwest Oncology Group, Ozark Health Ventures, LLC dba Cancer Research for the Ozarks, GRAND RAPIDS CLINICAL ONCOLOGY PROGRAM, G3041257426, SOUTHWEST ONCOLOGY GROUP STATISTICAL CENTER, G3126600779, G3144944009, Southeast Cancer Control Consortium, Inc, G3334379738, G3337849518, G3350348941, City of Hope Southwest Oncology Group Clinical Trials, G3710026009, G4094841028, G413878341, Southwest Oncology Group, Dayton Clinical Oncology Program, Southwest Oncology Group, G4527800867, G4719029039, G5125348268, G5504618518, UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM, G591690631, G6109875642, Southwest Oncology Group Treatment Grant, Southwest Oncology Group, SOUTHWEST ONCOLOGY GROUP STUDIES, University of Colorado Southwest Oncology Group, CENTRAL ILLINOIS COMMUNITY CLINICAL ONCOLOGY PROGRAM, Community Clinical Oncology Program, Virginia Mason Community Clinical Oncology Program, G763325562, ST Louis-Cape Girardeau CCOP, SOUTHWEST ONCOLOGY GROUP (UTAH), G860872252, PARTICIPATE AS MEMBER OF SOUTHWEST ONCOLOGY GROUP, G960417071, Montana Cancer Consortium CCOP, G971274320, Southwest Oncology Group/University of California, Davis
OpenAlex ID: W2058419129
FWCI: 2.014
Cites: 32
Cited by: 56
Related to: 10